|
17 Jun 2014
|
BMRC
|
Genome Institute of Singapore
|
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
|
Dieter Flesch-Janys,
Petra Seibold,
Anja Rudolph,
Graham G. Giles,
Laura Baglietto,
Gianluca Severi,
Christopher A. Haiman,
Brian E. Henderson,
Fredrick Schumacher,
Loic Le Marchand,
Vessela Kristensen,
Grethe I. Grenaker Alnæs,
Anne-Lise Borresen-Dale,
Silje Nord,
Robert Winqvist,
Yi Li,
Ute Hamann,
Diana Torres,
Hans U. Ulmer,
Thomas Rüdiger,
Chen-Yang Shen,
Chia-Ni Hsiung,
Katri Pylkäs,
Arja Jukkola-Vuorinen,
Mervi Grip,
Irene L. Andrulis,
Julia A. Knight,
Gord Glendon,
Sandrine Tchatchou,
Peter Devilee,
Robert Tollenaar,
Caroline Seynaeve,
Maartje Hooning,
Mieke Kriege,
Antoinette Hollestelle,
Ans van den Ouweland,
Nur Aishah Mohd Taib,
Pei-Ei Wu,
Shou-Tung Chen,
Soo Hwang Teo,
Cheng Har Yip,
Gwo Fuang Ho,
Keitaro Matsuo,
Hidemi Ito,
Hiroji Iwata,
Kazuo Tajima,
Daehee Kang,
Ji-Yeob Choi,
Sue K. Park,
Keun-Young Yoo,
Tom Maishman,
William J. Tapper,
Alison Dunning,
Mitul Shah,
Robert Luben,
Judith Brown,
Chiea Chuen Khor,
Diana M. Eccles,
Heli Nevanlinna,
Douglas Easton,
Keith Humphreys,
Jianjun Liu,
Per Hall,
Kamila Czene,
Sara Margolin,
Arto Mannermaa,
Veli-Matti Kosma,
Jaana M. Hartikainen,
Vesa Kataja,
Georgia Chenevix-Trench,
kConFab Investigators,
Kelly-Anne Phillips,
Laura J. Van ‘t Veer,
Sten Cornelissen,
Emiel Rutgers,
Jingmei Li,
Linda S. Lindström,
Jia N. Foo,
Sajjad Rafiq,
Melissa C. Southey,
Carmel Apicella,
Gillian S. Dite,
John L. Hopper,
Peter A. Fasching,
Lothar Haeberle,
Arif B. Ekici,
Matthias W. Beckmann,
Carl Blomqvist,
Taru A. Muranen,
Kristiina Aittomaki,
Annika Lindblom,
Marjanka K. Schmidt,
Paul D. P. Pharoah,
Kyriaki Michailidou,
Joe Dennis,
Manjeet K. Bolla,
Qin Wang,
Sue-Anne McLachlan,
Diether Lambrechts,
Bernard Thienpont,
Ann Smeets,
Hans Wildiers,
Jenny Chang-Claude
|
Nature Communications
|